date,title,source
Oct-31-18,"Reata Pharmaceuticals, Inc. to Report Third Quarter 2018 Financial Results and Provide an Update on Development Programs on Wednesday, November 7, 2018",GlobeNewswire
Nov-07-18,Edited Transcript of RETA earnings conference call or presentation 7-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-07-18,"Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-07-18,"Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs",GlobeNewswire
Nov-19-18,Edited Transcript of RETA earnings conference call or presentation 7-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-26-18,"Report: Exploring Fundamental Drivers Behind Reata Pharmaceuticals, Calyxt, SIFCO Industries, EchoStar, Tel-Instrument Electronics, and United States Antimony  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Dec-19-18,"Reata Pharmaceuticals, Inc. (RETA): Hedge Funds Are Snapping Up",Insider Monkey
Jan-03-19,"Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease",GlobeNewswire
Jan-04-19,2 Promising Biotech Stocks That Insiders Are Snapping Up,TheStreet.com
Jan-07-19,"Reata Pharmaceuticals, Inc. Appoints Geoffrey A. Block, M.D. as Vice President, Nephrology",GlobeNewswire
Feb-05-19,"Analysis: Positioning to Benefit within LPL Financial, The Andersons, Del Frisco's Restaurant Group, United Fire Group, Reata Pharmaceuticals, and Federal Agricultural Mortgage  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Feb-20-19,Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in Patients with Focal Segmental Glomerulosclerosis and in Patients From All Four Cohorts of PHOENIX,GlobeNewswire
Feb-21-19,"Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2018 Financials and to Provide an Update on Development Programs",GlobeNewswire
Feb-22-19,"Analysts Estimate Reata Pharmaceuticals, Inc. (RETA) to Report a Decline in Earnings: What to Look Out for",Zacks
Feb-25-19,"Who Has Been Buying Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Shares?",Simply Wall St.
Feb-28-19,"Reata Pharmaceuticals, Inc. (RETA) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Feb-28-19,"Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2018 Financials and Operating Results",GlobeNewswire
Mar-15-19,Edited Transcript of RETA earnings conference call or presentation 28-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Apr-02-19,Reata CEO on drug that shows signs of reversing kidney damage,CNBC Videos
Apr-30-19,"Reata Pharmaceuticals, Inc. (NASDAQ:RETA): When Will It Breakeven?",Simply Wall St.
May-01-19,"Did Hedge Funds Drop The Ball On Reata Pharmaceuticals, Inc. (RETA) ?",Insider Monkey
May-02-19,Reata Announces Presentation at the Annual CKD3 Chronic Kidney Disease Drug Development Summit,GlobeNewswire
May-02-19,"Reata Pharmaceuticals, Inc. to Report First Quarter 2019 Financials and to Provide an Update on Development Programs on May 9, 2019",GlobeNewswire
May-06-19,Biotech developing kidney disease treatment jumps after hedge fund recommendation at conference,CNBC
May-09-19,"Reata Pharmaceuticals, Inc. (RETA) Q1 2019 Earnings Call Transcript",Motley Fool
May-09-19,"Reata Pharmaceuticals, Inc. (RETA) Reports Q1 Loss, Lags Revenue Estimates",Zacks
May-09-19,"Reata Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results and an Update on Development Programs",GlobeNewswire
May-10-19,Edited Transcript of RETA earnings conference call or presentation 9-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-22-19,Edited Transcript of RETA earnings conference call or presentation 9-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-23-19,Edited Transcript of RETA earnings conference call or presentation 9-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-30-19,Reata Announces First Patient Enrolled in Phase 3 FALCON Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease,GlobeNewswire
Jun-05-19,"Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease",GlobeNewswire
Jun-06-19,Reata's (RETA) Kidney Candidate Gets Orphan Drug Status,Zacks
Jun-06-19,"The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering",Benzinga
